You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Escherichia coli Infections

Showing 1 - 25 of 9,100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Perinatal Transmission of MDR Bacteria

Recruiting
  • E. Coli Infection
  • Multi-antibiotic Resistance
    • Chicago, Illinois
      Prentice Women's Hospital
    Nov 20, 2023

    Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD

    Recruiting
    • Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
    • ExPEC9V
    • +2 more
    • Mechelen, Belgium
      Az Sint-Maarten
    Nov 13, 2023

    Patients With Infection by Resistant Microorganism

    Enrolling by invitation
    • Pneumonia
    • +10 more
    • Pathogen resistant phenotype
    • Sevilla, Spain
      Hospital Universitario Virgen Macarena
    May 18, 2023

    Staphylococcus Aureus and Escherichia Coli From Humans, Chicken

    Not yet recruiting
    • Drug Resistance, Microbial
      • (no location specified)
      Dec 7, 2022

      ry Dynamics of Escherichia Coli in Digestive Commensal Flora

      Recruiting
      • Escherichia Coli; Infection, Intestinal
        • Paris, France
        • +1 more
        Dec 9, 2021

        Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)

        Not yet recruiting
        • Shigella Infection
        • Enterotoxigenic Escherichia Coli Infection
        • strain CVD 1208S-122
        • Placebo
        • Baltimore, Maryland
          University of Maryland, Baltimore, University of Maryland School
        Jul 26, 2022

        E.Coli Infections, Bloodstream Infection Trial in Cincinnati (SNIPR001, Placebo)

        Active, not recruiting
        • E.Coli Infections
        • Bloodstream Infection
        • Cincinnati, Ohio
          Medpace Clinical Pharmacology
        Dec 1, 2022

        Determine Incidence of ETEC in Children and Infants in Lusaka

        Completed
        • Diarrhea Toddlers
        • Escherichia Coli Diarrhea
        • No intervention will be done
        • Lusaka, Zambia
        • +3 more
        Jul 19, 2022

        Gastroenteritis Escherichia Coli, Immunisation Trial in Dhaka (Placebo, Recombinant Double Mutant Heat-Labile Toxin

        Terminated
        Has Results
        • Gastroenteritis Escherichia Coli
        • Immunisation
        • Placebo
        • Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral enterotoxigenic Escherichia coli (ETEC) Vaccine
        • Dhaka, Bangladesh
          International Center for Diarrheal Disease Research Bangladesh -
        Dec 16, 2021

        Developing Microbials to Fight Extended-spectrum

        Active, not recruiting
        • Extended Spectrum Beta Lactamases (ESBL) E. Coli
        • examination of stool sample
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Division of Clinical Microbiology
        Aug 3, 2021

        Escherichia Coli Bacteremia, Klebsiella Bacteraemia, Enterobacter Bacteraemia Trial in Worldwide (Step down to oral

        Recruiting
        • Escherichia Coli Bacteremia
        • +5 more
        • Step down to oral antimicrobial therapy
        • IV antimicrobial therapy
        • Manama, Bahrain
        • +6 more
        Mar 26, 2022

        Collect Information About Invasive Disease Caused by

        Completed
        • E. Coli Infection
          • Durham, North Carolina
          • +7 more
          Sep 20, 2021

          Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

          Completed
          • Human Papillomavirus Infection
          • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
          • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
          • Nanjing, Jiangsu, China
            CDC, Jiangsu Province
          Jan 12, 2023

          Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

          Completed
          • Human Papilloma Virus Infection
          • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
          • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
          • Nanjing, Jiangsu, China
            CDC, Jiangsu Province
          Jan 12, 2023

          Collect Information About Invasive Disease Caused by

          Completed
          • E.Coli Infections
            • Durham, North Carolina
            • +7 more
            Sep 20, 2021

            Staphylococcus Aureus Infection Trial in Xuzhou (Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0-3-7,

            Completed
            • Staphylococcus Aureus Infection
            • Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0-3-7
            • +3 more
            • Xuzhou, Jiangsu, China
              Suining County Center for Disease Control and Prevention
            Mar 28, 2021

            Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

            Active, not recruiting
            • Human Papillomavirus Infection
            • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
            • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
            • Guangzhou, Guangdong, China
            • +2 more
            Dec 30, 2022

            Multi-Drug Resistant Organism: Study of Highly Resistant

            Completed
            • E Coli Infection
            • no Intervention
            • Torrance, California
            • +12 more
            Jul 26, 2021

            Enterotoxigenic Escherichia Coli Infection, Diarrhea Trial in Baltimore (VLA1701, Placebo, Challenge Strain)

            Completed
            Has Results
            • Enterotoxigenic Escherichia Coli Infection
            • Diarrhea
            • VLA1701
            • +2 more
            • Baltimore, Maryland
              Department of International Health Johns Hopkins University
            Mar 29, 2021

            Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome Trial in Canada, United States (Infusion

            Recruiting
            • Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection
            • Hemolytic-Uremic Syndrome
            • Infusion of 200% maintenance fluids as balanced crystalloid IV solution
            • Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution
            • Birmingham, Alabama
            • +25 more
            Sep 19, 2022

            Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

            Active, not recruiting
            • Human Papillomavirus Infection
            • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
            • GARDASIL® 9
            • Kunming, Yunnan, China
              Yunnan Center for Disease Prevention and Control
            Dec 23, 2022

            Escherichia Coli Infection Trial in Silver Spring (Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5, Recombinant fimbrial

            Completed
            Has Results
            • Escherichia Coli Infection
            • Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5
            • +2 more
            • Silver Spring, Maryland
              Walter Reed Army Institute of Research Clinical trial Center
            Feb 10, 2021

            Extraintestinal Pathogenic Escherichia Coli Prevention Trial in Worldwide (ExPEC10V, ExPEC4V, Prevnar 13)

            Active, not recruiting
            • Extraintestinal Pathogenic Escherichia Coli Prevention
            • ExPEC10V
            • +3 more
            • Huntsville, Alabama
            • +28 more
            Jan 17, 2023

            Diarrhea Trial in Silver Spring (CssBA, dmLT)

            Completed
            Has Results
            • Diarrhea
            • CssBA
            • dmLT
            • Silver Spring, Maryland
              Walter Reed Army Institute of Research Clinical Trial Center
            Dec 10, 2020

            Hemolytic-Uremic Syndrome Trial in Calgary (D5-0.9%NS, Routine home oral rehydration)

            Withdrawn
            • Hemolytic-Uremic Syndrome
            • Calgary, Alberta, Canada
              Alberta Children's Hospital
            Nov 5, 2020